Indeed, the observed high variability in adult Pmp22 transgenic rats at onset may underlie the lack of significance after treatment and may reflect the ongoing de- and remyelination in adult peripheral nerves of CMT1A rats. This evidence concerns the gene PMP22 and Charcot-Marie-Tooth disease type 1A.